Protagenic Therapeutics, Inc. (PTIX)
OTCMKTS · Delayed Price · Currency is USD
0.6499
0.00 (0.00%)
At close: May 15, 2026
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $1.18 million as of May 19, 2026.
Market Cap
1.18M
Enterprise Value
2.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.65
Market Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from 9.64M to 1.18M, a decrease of -87.80%. That is a compound annual growth rate of -88.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 1.18M | -53.23% |
| Dec 31, 2025 | 2.52M | -73.91% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| inTerra Resources | 1.47M |
| ZyVersa Therapeutics | 1.46M |
| International Stem Cell | 1.42M |
| Lyra Therapeutics | 1.33M |
| Eloxx Pharmaceuticals | 1.33M |
| Avenue Therapeutics | 1.32M |
| Abpro Holdings | 1.21M |
| Neon Bloom | 1.21M |